22.12.2014
- Swiss pharmaceutical producer group Roche said it would discontinue a late-stage study of investigational anti-amyloid medicine gantenerumab in pre-dementia Alzheimer's disease...
17.07.2014
- Swiss drugmaker Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given...
